한스바이오메드

042520KOSDAQ의료용품 및 기타 의약 관련제품 제조업

44.1 / 100

Reference Date: 2026-07-24

Financial Score9.5 / 40

News Sentiment20.6 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Plunged 16.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HansBioMed, established in 1999, develops, manufactures, and sells skin and bone tissue implants and medical devices. Its key products, Bella Cell HD and SureFuse, account for approximately 61% of sales, with global expansion through overseas subsidiaries in the U.S., Thailand, and the U.K. The company continues to invest in R&D for regenerative medicine and new medical technologies.

Number of Employees

289people

Average Salary

41.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.184.0Point

PBR

8.80Industry Average 1.090.0Point

8.1x industry avg (risky)

ROE

-63.51Industry Average -4.893.5Point

13.0x industry avg (excellent)

Debt Ratio

33.90Industry Average 6.860.0Point

4.9x industry avg (risky)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲7.3% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼2061.7% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -42.1% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 82.5

Positive
가슴보형물 브랜드 '바운스', 2026 레드닷 디자인 어워드 수상
한스바이오메드의 가슴보형물 브랜드 Bounces가 레드닷 디자인 어워드에서 본상 수상으로 브랜드 인지도와 디자인 경쟁력이 강화되었다.
Positive
“셀르디엠 연 매출 300억 목표…미국·호주로 시장 확대”
한스바이오메드의 김근영 대표가 휴젤과의 협력으로 해외 시장 확장 및 신제품 수출 가속화를 발표하며 긍정적인 전망을 제시했다.
Positive
한스바이오메드, 국민연금 지분 취득 공시에…주가 7%대 상승세 [Why...
한스바이오메드의 국민연금 지분 취득 공시로 인해 주가가 7% 이상 상승했다.

Detailed Momentum

52-week position3.0Point

52w lower range (28%)

Current 20,900Won52-week high 55,70052-week low 7,030

1-month return0.0Point

1m -16.57% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral주식등의대량보유상황보고서(약식)2026-07-02
Neutral주식등의대량보유상황보고서(약식)2026-07-01